TY - JOUR
T1 - Trends and Outcomes of Myocardial Infarction in Patients With Previous Coronary Artery Bypass Surgery
AU - Megaly, Michael
AU - Sedhom, Ramy
AU - Elbadawi, Ayman
AU - Buda, Kevin
AU - Basir, Mir B.
AU - Garcia, Santiago
AU - Brilakis, Emmanouil S.
AU - Rinfret, Stephane
AU - Alaswad, Khaldoon
N1 - Funding Information:
The authors disclose the following relations: Dr. Khaldoon Alaswad: consulting/speaker honoraria from Boston Scientific, Cardiovascular Systems, Abbott Vascular, Teleflex; Dr. Mir Basir: consulting/speaker Abbott Vascular, Abiomed, Cardiovascular Systems, Chiesi, ZOLL. Dr. Emmanouil Brilakis: consulting/speaker honoraria from Abbott Vascular, American Heart Association (Associate Editor, Circulation), Amgen, Asahi Intecc, BIOTRONIK, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), ControlRad, CSI, Elsevier, GE Healthcare (Little Chalfont, United Kingdom), IMDS, Infraredx, Medicure, Medtronic, Opsens, Siemens, Teleflex; research support from Boston Scientific, GE Healthcare; owner, Hippocrates LLC; shareholder, MHI Ventures, Cleerly, Stallion Medical. Dr. Stephane Rinfret: consultant Boston Scientific, Abiomed, Abbott Vascular, and Soundbite Medical. Dr. Santiago Garcia: consultant for Surmodics, Osprey Medical, Medtronic, Edwards Lifesciences, Abbott; grant support from Edwards Lifesciences and the US Department of Veterans Affairs’ Office of Research and Development. The remaining authors have no conflicts of interests to declare.
Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022/9/15
Y1 - 2022/9/15
N2 - Data on myocardial infarction (MI) treatment in patients with previous coronary artery bypass grafting (CABG) is limited. We queried the Nationwide Readmissions Database to identify hospitalizations of patients with MI from 2016 to 2019. Among hospitalized patients presenting with MI, 10.3% had previous CABG. Patients with MI who had previous CABG were less likely to be revascularized than those without previous CABG for both ST-segment elevation MI (STEMI) (46.4% vs 68.4%) and non-ST-segment elevation MI (NSTEMI) (30.8% vs 36.7%). CABG was associated with a lower risk of death in NSTEMI patients (odds ratio [OR] 0.84, 95% confidence interval [CI] 0.82 to 0.86), but a higher risk in STEMI patients (OR 1.06, 95% CI 1.01 to 1.13). Revascularization was associated with a lower risk of in-hospital death in patients with previous CABG presenting with STEMI (OR 0.30, 95% CI 0.26 to 0.35) and NSTEMI (OR 0.21, 95% CI 0.19 to 0.23).
AB - Data on myocardial infarction (MI) treatment in patients with previous coronary artery bypass grafting (CABG) is limited. We queried the Nationwide Readmissions Database to identify hospitalizations of patients with MI from 2016 to 2019. Among hospitalized patients presenting with MI, 10.3% had previous CABG. Patients with MI who had previous CABG were less likely to be revascularized than those without previous CABG for both ST-segment elevation MI (STEMI) (46.4% vs 68.4%) and non-ST-segment elevation MI (NSTEMI) (30.8% vs 36.7%). CABG was associated with a lower risk of death in NSTEMI patients (odds ratio [OR] 0.84, 95% confidence interval [CI] 0.82 to 0.86), but a higher risk in STEMI patients (OR 1.06, 95% CI 1.01 to 1.13). Revascularization was associated with a lower risk of in-hospital death in patients with previous CABG presenting with STEMI (OR 0.30, 95% CI 0.26 to 0.35) and NSTEMI (OR 0.21, 95% CI 0.19 to 0.23).
UR - http://www.scopus.com/inward/record.url?scp=85134804469&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85134804469&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2022.06.002
DO - 10.1016/j.amjcard.2022.06.002
M3 - Article
C2 - 35870988
AN - SCOPUS:85134804469
SN - 0002-9149
VL - 179
SP - 11
EP - 17
JO - American Journal of Cardiology
JF - American Journal of Cardiology
ER -